Revenue - Schedule of Disaggregated Revenues (Parenthetical) (Details) - USD ($)			1 Months Ended		12 Months Ended
		Dec. 17, 2021	Jan. 31, 2022	Dec. 31, 2021	Dec. 31, 2024	Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalties, license and other revenues	[1]				$ 1,350,000	$ 1,357,000
Revenue recognized included in deferred revenue					$ 30,000	$ 87,000
Roche Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront payment		$ 50,000,000	$ 50,000,000	$ 50,000,000
Roche Agreement [Member] | Upfront License Fees [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront payment			$ 50,000,000

[1] Of the royalties, license and other revenues recognized each period, $30,000 and $87,000 was included within deferred revenues as contract liabilities as of January 1, 2024 and 2023, respectively.